BHCM
CLMT icon

Brevan Howard Capital Management’s Calumet Specialty Products CLMT Stock Holding History

Brevan Howard Capital Management’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$372K Sell
10,322
-6,499
-39% -$218K ﹤0.01% 1589
2026
Q1 		$604K Buy
+16,821
New +$436K 0.01% 1190
2025
Q2 		– Sell
-40,737
Closed -$517K – 1859
2025
Q1 		$517K Buy
+40,737
New +$640K 0.01% 722

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Brevan Howard Capital Management's CLMT Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Calumet Specialty Products (CLMT) stake by 39% in Q2 2026, selling an estimated $218K and leaving 10,322 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #1589.

Brevan Howard Capital Management first reported a position in CLMT in Q1 2025 and has held it in 3 quarters since. The position peaked at $604K in Q1 2026. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Brevan Howard Capital Management held 10,322 shares of Calumet Specialty Products worth $372K as of Q2 2026.
  • Brevan Howard Capital Management sold 6,499 Calumet Specialty Products shares in Q2 2026, an estimated $218K.
  • Calumet Specialty Products made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1589 holding.
  • Brevan Howard Capital Management first reported a position in Calumet Specialty Products in Q1 2025 and has held it in 3 quarters since.
  • Brevan Howard Capital Management's Calumet Specialty Products position peaked at $604K in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.